ALDEYRA THERAPEUTICS, INC. Unrecognized Tax Benefits, Interest on Income Taxes Expense
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Unrecognized Tax Benefits, Interest on Income Taxes Expense of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense · last filed 2025-02-28
- ALDEYRA THERAPEUTICS, INC. unrecognized tax benefits, interest on income taxes expense for fiscal 2024 was $0.00.
- ALDEYRA THERAPEUTICS, INC. unrecognized tax benefits, interest on income taxes expense for fiscal 2023 was $0.00.
- ALDEYRA THERAPEUTICS, INC. unrecognized tax benefits, interest on income taxes expense for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Interest on Income Taxes Expense 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2023-12-31 | $0.00 10-K · filed 2024-03-07 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |